Daré Bioscience
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3655 Nobel Dr Ste 260, San Diego, Califo...Phone Number
(858) 926-7655Website
www.darebioscience.comRevenue
<$5 MillionStock Symbol
DAREIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Daré Bioscience
Daré Bioscience is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for womens health. The companys mission is to identify, develop and bring to market a diverse portfolio of differentiated therapies that expand treatment options, improve outcomes and facilitate convenience for women, primarily in the areas of contraception, vaginal health, sexual health, and fertility.Explore more
Daré Bioscience Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Daré Bioscience your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Daré Bioscience, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Daré Bioscience has recently received funding, and reach out quickly before it becomes old news!
Click to see if Daré Bioscience had a recent Job posting/layoffs
Check out if Daré Bioscience is spiking on competitors!
Product Launch: Get notified when Daré Bioscience launches new products
Funding: Get notified immidiatlly once Daré Bioscience has new funding data
Congratulate Masked Content for being promoted to Masked Content at Daré Bioscience
Earning: See what the market has to say on Daré Bioscience recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Daré Bioscience
Compare insights from companies similar to Daré Bioscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Daré Bioscience is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Daré Bioscience is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Daré Bioscience.
Daré Bioscience financials insights
Gather financial insights about Daré Bioscience, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Multiple Rounds
$22.1M
2023
Other Financing Round
$12M
2024
Grant
$2.5M
Daré Bioscience Tech Stack
A closer look at the technologies used by Daré Bioscience
Most Recent Scoops
Person-Based
Spending/Investment, Product Development
Person-Based
Earnings, Finance
Person-Based
Earnings, Finance
Person-Based
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Daré Bioscience News & Media
Daré Bioscience Receives NIH Funding Award Notice to Advance DARE-HPV, its Novel Investigational Treatment for Persistent High-Risk HPV Infection, the Most Common Cause of Cervical Cancer
SAN DIEGO, May 26, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and real-world solutions, today announced receipt of a Notice of Award from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), obligating the second and final tranche of $1.0 million under the previously announced up toDaré Bioscience Initiates Phase 2 Study of DARE-HPV, a Novel Pharmacologic Treatment for Persistent High-Risk HPV Infection with No FDA-Approved Therapies
Each year, an estimated six million women in the United States acquire a high-risk HPV infection — and there are no FDA-approved treatmentsPositive Interim Phase 3 Results Highlight Potential of Ovaprene®, Novel Hormone-Free Contraceptive
Second Positive DSMB Review Supports Continued Study ProgressDaré Bioscience to Host First Quarter 2026 Financial Results and Company Update Conference Call and Webcast on May 14, 2026
SAN DIEGO, May 07, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world solutions, will host a conference call and live webcast at 4:30 p.m. Eastern Time on Thursday, May 14, 2026, to review its financial results for the quarter ended March 31, 2026 and to provide a company update.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Daré Bioscience
Sign Up For FreeTo access detailed company insights
Daré Bioscience is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for womens health. The companys mission is to identify, develop and bring to market a diverse portfolio of differentiated therapies that expand treatment options, improve outcomes and facilitate convenience for women, primarily in the a... Read More
